Pathology Part 1 Flashcards
Features of acute asthma
Worsening dyspnoea, wheeze and cough that is not responding to salbutamol
Maybe triggered by a respiratory tract infection
Why is a normal CO2 in acute asthma not a good sign?
Indicates exhaustion and should, therefore, be classified as life-threatening.
Moderate acute asthma attack features
PEFR 50-75% best or predicted
Speech normal
RR < 25 / min
Pulse < 110 bpm
Severe acute asthma attack features
PEFR 33 - 50% best or predicted
Can’t complete sentences
RR > 25/min
Pulse > 110 bpm
Life-threatening acute asthma attack features
PEFR < 33% best or predicted Oxygen sats < 92% Silent chest, cyanosis or feeble respiratory effort Bradycardia, dysrhythmia or hypotension Exhaustion, confusion or coma
The classification of acute asthma
Moderate
Severe
Life-threatening
When is a chest x-ray indicated in acute asthma attacks?
life-threatening asthma
suspected pneumothorax
failure to respond to treatment
When is hospital admission indicated in acute asthma attacks?
- Life-threatening asthma attack
- Severe asthma features if they don’t respond to initial treatment
- Previous near-fatal asthma attack
- Pregnancy,
- Presentation at night
When is oxygen indicated in acute asthma attacks?
Acutely unwell should be started on 15L of supplemental via a non-rebreathe mask, which can then be titrated down to a flow rate where they are able to maintain a SpO₂ 94-98%.
Criteria for discharge after acute asthma attacks
Stable on their discharge medication (i.e. no nebulisers or oxygen) for 12–24 hours
Inhaler technique checked and recorded
PEF >75% of best or predicted
Management of acute asthma attacks
- SABA
- All patients given 40-50mg of prednisolone orally (PO) daily, continued for at least five days or until the patient recovers from the attack
- Nebulised ipratropium bromide given 3rd line if needed
- IV magnesium sulphate
- IV aminophylline after consultation with senior medical staff
Acute bronchitis
A type of chest infection which causes inflammation of the trachea and major bronchi and is therefore associated with oedematous large airways and the production of sputum.
Leading cause of acute bronchitis
Viral infection
How long does acute bronchitis last?
Usually resolves before 3 weeks, however, 25% of patients will still have a cough beyond this time.
Features of acute bronchitis
Typically present with an acute onset of:
> cough: may or may not be productive
> sore throat
> rhinorrhoea
> wheeze
> Low grade fever (may/may not be present)
Chest examination findings in acute bronchitis
Majority of patients with have a normal chest examination, however, some may have Low-grade
fever & Wheeze
Differentiating acute bronchitis from pneumonia
Sputum, wheeze, breathlessness may be absent in acute bronchitis whereas at least one tends to be present in pneumonia.
Examination: No other focal chest signs in acute bronchitis other than wheeze. Systemic features (malaise, myalgia, and fever) may be absent in acute bronchitis, whereas they tend to be present in pneumonia.
Investigations in acute bronchitis
Typically a clinical diagnosis
Management of acute bronchitis
- analgesia
- good fluid intake
- consider antibiotic therapy
- doxycycline first-line - cannot be used in children or pregnant women - amoxicillin is alternative
When is antibiotic therapy indicated in acute bronchitis?
- Systemically very unwell
- Pre-existing co-morbidities
- CRP of 20-100mg/L (offer delayed prescription) or a CRP >100mg/L (offer antibiotics immediately)
What antibiotic is first line in acute bronchitis?
Doxycycline - cannot be used in children or pregnant women - amoxicillin is alternative
Features Acute exacerbation of COPD
- Increase in dyspnoea, cough, wheeze
- Increase in sputum suggestive of an infective cause
- May be hypoxic and in some cases have acute confusion
The most common bacterial organisms that cause infective exacerbations of COPD
Haemophilus influenzae (most common cause)
Streptococcus pneumoniae
Moraxella catarrhalis
Most common bacteria that causes infective exacerbations of COPD
Haemophilus influenzae
Management of infective exacerbations of COPD
Increase frequency of bronchodilator use and consider giving via a nebuliser
Prednisolone 30 mg daily for 5 days
Give oral antibiotics if sputum is purulent or signs of pneumonia - amoxicillin or clarithromycin or doxycycline first-line
When are antibiotics indicated in infective exacerbations of COPD?
Give oral antibiotics if sputum is purulent or signs of pneumonia - amoxicillin or clarithromycin or doxycycline first-line
What are the first-line antibiotics for infective exacerbations of COPD?
Amoxicillin or clarithromycin or doxycycline first-line
Acute respiratory distress syndrome (ARDS)
Caused by the increased permeability of alveolar capillaries leading to fluid accumulation in the alveoli - life-threatening condition where the lungs cannot provide the body’s vital organs with enough oxygen.
Causes of Acute respiratory distress syndrome (ARDS)
infection: sepsis, pneumonia massive blood transfusion trauma smoke inhalation acute pancreatitis cardio-pulmonary bypass
Features of Acute respiratory distress syndrome (ARDS)
> Acute onset and severe > dyspnoea > elevated respiratory rate > bilateral lung crackles > low oxygen saturations
Key investigations in Acute respiratory distress syndrome ARDS
A chest x-ray and arterial blood gases
Management of Acute respiratory distress syndrome ARDS
- ITU
- Oxygenation/ventilation to treat the hypoxaemia
- Treat underlying cause e.g. antibiotics for sepsis
- Strategies such as prone positioning and muscle relaxation shown to improve outcome in ARDS
Adult respiratory distress syndrome
Acute condition characterized by bilateral pulmonary infiltrates and severe hypoxemia (PaO2/FiO2 ratio < 200) in the absence of evidence for cardiogenic pulmonary oedema.
Adult respiratory distress syndrome causes
Sepsis
Direct lung injury
Trauma
Acute pancreatitis
Long bone fracture or multiple fractures (through fat embolism)
Head injury (causes sympathetic nervous stimulation which leads to acute pulmonary hypertension)
The two stages of Adult respiratory distress syndrome
Early stages consist of an exudative phase of injury with associated oedema.
The later stage is one of repair and consists of fibroproliferative changes. Subsequent scarring may result in poor lung function.
Features of Adult respiratory distress syndrome
Acute dyspnoea and hypoxaemia hours/days after event
Multi organ failure
Rising ventilatory pressures
Management of Adult respiratory distress syndrome
> Treat the underlying cause
Antibiotics (if signs of sepsis)
Negative fluid balance i.e. Diuretics
Recruitment manoeuvres such as prone ventilation, use of positive end expiratory pressure
Allergic bronchopulmonary aspergillosis
Results from an allergy to Aspergillus spores. In the exam questions often give a history of bronchiectasis and eosinophilia.
Allergic bronchopulmonary aspergillosis features
- Bronchoconstriction: wheeze, cough, dyspnoea.
- Patients may have a previous label of asthma
- Bronchiectasis (proximal)
Investigations in Allergic bronchopulmonary aspergillosis
> eosinophilia
flitting CXR changes
positive radioallergosorbent (RAST) test to Aspergillus
positive IgG precipitins (not as positive as in aspergilloma)
raised IgE
Management Allergic bronchopulmonary aspergillosis
- oral glucocorticoids
2. itraconazole as a second-line agent
Three main types of altitude-related disorders
Acute mountain sickness (AMS), which may progress to High altitude pulmonary oedema (HAPE) or high altitude cerebral oedema (HACE).
Features of Acute mountain sickness
Develop gradually over 6-12 hours and potentially last a number of days:
> headache
> nausea
> fatigue
HAPE/HACE features
Some people above 4,000m go onto develop high altitude pulmonary oedema (HAPE) or high altitude cerebral oedema (HACE), potentially fatal conditions
> HAPE presents with classical pulmonary oedema features
> HACE presents with headache, ataxia, papilloedema
Management of high altitude pulmonary oedema (HAPE)
- descent
- nifedipine, dexamethasone, acetazolamide,
- phosphodiesterase type V inhibitors*
- oxygen if available
Management of high altitude cerebral oedema (HACE)
- descent
2. dexamethasone
Alpha-1 antitrypsin (A1AT) deficiency
Common inherited condition caused by a lack of a protease inhibitor normally produced by the liver.
The role of A1AT is to protect cells from enzymes such as neutrophil elastase. It classically causes emphysema in patients who are young and non-smokers.
What disease does Alpha-1 antitrypsin (A1AT) deficiency cause?
Causes emphysema (i.e. chronic obstructive pulmonary disease) in patients who are young and non-smokers.
The role of Alpha-1 antitrypsin
To protect cells from enzymes such as neutrophil elastase.
Inheritance of Alpha-1 antitrypsin (A1AT) deficiency
Autosomal recessive
Features of Alpha-1 antitrypsin (A1AT) deficiency
- Usually have PiZZ genotype
- Panacinar emphysema, mostly in lower lobes of lungs
- Liver: cirrhosis and hepatocellular carcinoma in adults, cholestasis in children
Investigations in Alpha-1 antitrypsin (A1AT) deficiency
- A1AT concentrations
2. spirometry: obstructive picture
Management of Alpha-1 antitrypsin (A1AT) deficiency
- no smoking
- supportive: bronchodilators, physiotherapy
- IV alpha1-antitrypsin protein concentrates
- Lung volume reduction surgery
- lung transplantation
Normal PaO2 levels
Pa02 on air should be >10 kPa
Less than this is hypoxaemic
Acidaemic and alkalaemic pH
Acidaemic (pH <7.35)
Alkalaemic (pH >7.45)
PaCO2 > 6.0 kPa
Suggests a respiratory acidosis (or respiratory compensation for a metabolic alkalosis)
PaCO2 < 4.7 kPa
Suggests a respiratory alkalosis (or respiratory compensation for a metabolic acidosis)
Bicarbonate < 22 mmol/l (or a base excess < - 2mmol/l)
Suggests a metabolic acidosis (or renal compensation for a respiratory alkalosis)
Bicarbonate > 26 mmol/l (or a base excess > + 2mmol/l)
Suggests a metabolic alkalosis (or renal compensation for a respiratory acidosis)
Low pH + high PaCO2
Acidosis
High pH + low PaCO2
Alkalosis
Low pH + low bicarbonate
Acidosis
High pH + high bicarbonate
Akalosis
Asbestos
Can cause a variety of lung disease from benign pleural plaques to mesothelioma.
Pleural plaques
Benign and do not undergo malignant change. They, therefore don’t require any follow-up. Most common form of asbestos-related lung disease and generally occur after a latent period of 20-40 years.
Pleural thickening
Asbestos exposure may cause diffuse pleural thickening in a similar pattern to that seen following an empyema or haemothorax. The underlying pathophysiology is not fully understood.
Asbestosis
The severity of asbestosis is related to the length of exposure. This is in contrast to mesothelioma where even very limited exposure can cause disease. The latent period is typically 15-30 years. Asbestosis typically causes lower lobe fibrosis.
A chronic lung condition that is caused by prolonged exposure to high concentrations of asbestos fibers in the air.
Lung changes in Asbestosis
Typically causes lower lobe fibrosis
Asbestosis features
As with other forms of lung fibrosis the most common symptoms are shortness-of-breath and reduced exercise tolerance.
Mesothelioma
A malignant disease of the pleura. Crocidolite (blue) asbestos is the most dangerous form. Mesothelioma can occur even with very limited exposure to asbestos
Features of Mesothelioma
- progressive shortness-of-breath
- chest pain
- pleural effusion
Aspiration pneumonia
A pneumonia that develops as a result of foreign materials gaining entry to the bronchial tree, usually oral or gastric contents such as food and saliva.
Risk factors for the development of aspiration pneumonia
Poor dental hygiene Swallowing difficulties Prolonged hospitalization or surgical procedures Impaired consciousness Impaired mucociliary clearance
Lung changes in Aspiration pneumonia
The right middle and lower lung lobes are the most common sites affected, due to the larger calibre and more vertical orientation of the right main bronchus.
Most common bacteria to cause infection in Aspiration pneumonia
Streptococcus pneumoniae
Staphylococcus aureus
Haemophilus influenzae
Pseudomonas aeruginosa
Most common chronic respiratory disorder encountered in clinical practice
Asthma
Asthma
Defined as a chronic inflammatory disorder of the airways secondary to type 1 hypersensitivity. Symptoms are variable and recurring and manifest as reversible bronchospasm resulting in airway obstruction.
Risk factors for Asthma
- personal or family history of atopy
- Maternal smoking, viral infection during pregnancy 3. Low birth weight
- Not being breastfed
- Maternal smoking around child
- Exposure to high concentrations of allergens
- Air pollution
- ‘hygiene hypothesis’
Patients with asthma also suffer from other IgE-mediated atopic conditions; what are they?
- atopic dermatitis (eczema)
2. allergic rhinitis (hay fever)
Occupational asthma
Type of asthma caused by exposure to inhaled irritants in the workplace. Diagnosed by observing reduced peak flows during the working week with normal readings when not at work.
Symptoms and signs of asthma
- cough: often worse at night
- dyspnoea
- ‘wheeze’, ‘chest tightness’
- expiratory wheeze on auscultation
- reduced peak expiratory flow rate (PEFR)
Spirometry
Test which measures the amount (volume) and speed (flow) of air during exhalation and inhalation.
Categorizes respiratory disorders as either obstructive or restrictive.
FEV1
Forced expiratory volume - volume that has been exhaled at the end of the first second of forced expiration
FVC
Forced vital capacity - volume that has been exhaled after a maximal expiration following a full inspiration
Typical spirometry results in asthma
FEV1 - significantly reduced
FVC - normal
FEV1% (FEV1/FVC) < 70%
Investigations in asthma patients over 17
Spirometry with a bronchodilator reversibility test
All patients should have a FeNO test
Chest x-ray: particular in older patients or those with a history of smoking
Short-acting beta-agonists (SABA)
Salbutamol
Inhaled corticosteroids (ICS)
Beclometasone
Dipropionate
Fluticasone
Propionate
Long-acting beta-agonists (LABA)
Salmeterol
Leukotriene receptor antagonists
Monteleukast
Maintenance and reliever therapy (MART)
A form of combined ICS and LABA treatment in which a single inhaler, containing both ICS and a fast-acting LABA, is used for both daily maintenance therapy and the relief of symptoms as required.
Side effects of Short-acting beta-agonists (SABA)
> Trembling, particularly in the hands.
Nervous tension.
Headaches
Suddenly noticeable heartbeats (palpitations)
Muscle cramps
Inhaled corticosteroids (ICS) side effects
Candidiasis and stunted growth in children
LABA side effects
Shaking of a part of your body that you cannot control headache nervousness dizziness cough
Investigations in asthma patients under 16
All patients should have spirometry with a bronchodilator reversibility (BDR) test
FeNO test should be requested if there is normal spirometry or obstructive spirometry with a negative bronchodilator reversibility (BDR) test
Management of asthma
> SABA > SABA + low-dose ICS > SABA + low-dose ICS + LTRA > SABA + low-dose ICS + LABA > Continue LTRA depending on response to LTRA > SABA +/- LTRA > Switch ICS/LABA for a low-dose ICS MART > SABA +/- LTRA + medium-dose ICS MART > SABA +/- LTRA + high-dose ICS MART
Low dose ICS
<= 400 micrograms budesonide or equivalent
Moderate dose ICS
400 micrograms - 800 micrograms budesonide or equivalent
High dose ICS
> 800 micrograms budesonide or equivalent
Common chemicals that cause occupational asthma
ocyanates - spray painting and foam moulding using adhesives platinum salts soldering flux resin glutaraldehyde flour epoxy resins proteolytic enzymes
Atelectasis
A common postoperative complication in which basal alveolar collapse can lead to respiratory difficulty. It is caused when airways become obstructed by bronchial secretions.
A complete or partial collapse of the entire lung or area (lobe) of the lung. It occurs when the tiny air sacs (alveoli) within the lung become deflated or possibly filled with alveolar fluid. Atelectasis is one of the most common breathing (respiratory) complications after surgery
Atelectasis features
Should be suspected in the presentation of dyspnoea and hypoxaemia around 72 hours postoperatively
Atelectasis management
> positioning the patient upright
> chest physiotherapy: breathing exercises
Most common causes of bilateral hilar lymphadenopathy
Sarcoidosis and tuberculosis
All causes of bilateral hilar lymphadenopathy
> lymphoma/other malignancy > pneumoconiosis e.g. berylliosis > fungi e.g. histoplasmosis, coccidioidomycosis > Sarcoidosis > Tuberculosis
Bronchiectasis
Describes a permanent dilatation of airways secondary to chronic infection or inflammation
Causes of Bronchiectasis
Post-infective: tuberculosis, measles, pertussis, Pneumonia
Cystic fibrosis
Bronchial obstruction e.g. lung cancer/foreign body
Immune deficiency: selective IgA, Hypogammaglobulinaemia
Allergic bronchopulmonary aspergillosis (ABPA)
Yellow nail syndrome
Management of Bronchiectasis
Physical training (e.g. inspiratory muscle training)
Postural drainage
Antibiotics for exacerbations + long-term rotating antibiotics in severe cases
Bronchodilators in selected cases
Immunisations
Surgery in selected cases (e.g. Localised disease)
Most common organisms isolated from patients with bronchiectasis
Haemophilus influenzae (most common)
Pseudomonas aeruginosa
Klebsiella spp.
Streptococcus pneumoniae
Most common bacteria isolated from patients with bronchiectasis
Haemophilus influenzae
Chest drain
A tube inserted into the pleural cavity which creates a one-way valve, allowing movement of air or liquid out of the cavity.
Chest drain indications
> Pleural effusion > Empyema > Haemothorax > Haemopneumothorax > Chylothorax > Pneumothorax not suitable for conservative management or aspiration
Chest drain contraindications
- INR > 1.3
- Platelet count < 75
- Pulmonary bullae
- Pleural adhesions
Insertion of chest drain
Patient should be positioned in a supine position or at a 45º angle.
Forearm may be positioned behind the patient’s head to allow easy access to the axilla.
Identify the 5th intercostal space in the midaxillary line.
Chest drain complications
- Failure of insertion
- Bleeding
- Infection
- Penetration of the lung
- Re-expansion pulmonary oedema
Re-expansion pulmonary edema
Uncommon complication following drainage of a pneumothorax or pleural effusion. Symptoms include cough, chest discomfort and hypoxemia; if the edema is severe, shock and death may ensue.
How to prevent re-expansion pulmonary oedema
Recommended that the drain tubing should be clamped regularly in the event of rapid fluid output i.e. drain output should not exceed 1L of fluid over a short period of time (less than 6 hours).
When are large bore chest drains used?
Trauma and haemothorax drainage